Albumin-Bilirubin Grade as a Three- Month Survival Predictor in Hepatocellular Carcinoma Patients after Initial Transarterial Chemoembolization (ALBI Grade Predicting Survival in HCC Treated With TACE)

Ummi Maimunah and Andri Pramana Restu and Iswan Abbas Nusi and Herrry Purbayu and Titong Sugihartono and Ulfa Kholili and Budi Widodo and Muhammad Miftahussurur and Husin Thamrin and Amie Vidyani and Poernomo Boedi Setiawan (2020) Albumin-Bilirubin Grade as a Three- Month Survival Predictor in Hepatocellular Carcinoma Patients after Initial Transarterial Chemoembolization (ALBI Grade Predicting Survival in HCC Treated With TACE). Systemathic Reviews in Pharmacy, 11 (5). pp. 205-208. ISSN 0976-2779

[img] Text (Artikel)
1. Albumin-Bilirubin Grade as a Three-Month Survival Predictor in Hepatocellular Carcinoma Patients.pdf
Download (398kB)
[img] Text (Kesesuaian Bidang Ilmu)
1. Kualitas Karil dan Kesesuaian Bidang Ilmu-27-9-2022.pdf
Download (165kB)
[img] Text (Similarity)
1. Albumin Bilirubin Grade as a Three Month Survival Predictor in Hepatocellular Carcinoma Patients after Initial Trans.pdf
Download (1MB)
[img]
Preview
 Image (Korespondensi)
1. Korespondensi_2023-04-13.jpeg
Download (72kB) | Preview
Official URL: https://www.sysrevpharm.org/abstract/albuminbiliru...

Abstract

One of hepatocellular carcinoma (HCC) therapeutic modality is transarterial chemoembolization (TACE). The albumin-bilirubin (ALBI) grade is amongst the newest of prognostic scores published to predict survival. The aim of this study was to analzye the ALBI grade as a three-month survival predictor in HCC patients after initial TACE. This was a retrospective analytic observational study identifying patients that underwent initial TACE from January 2013 to December 2017 in Dr. Soetomo General Hospital, Surabaya. Data were collected before treatment and analyzed to evaluate ALBI grade as a survival predictor. Out of 134 HCC patients, the subjects consisted of 100 (74.6%) male subjects and 34 (25.4%) female subjects. There were 25 (18.7%), 98 (73.1%), dan 11 (8.2%) subjects who were classified into to ALBI 1, ALBI 2, and ALBI 3, respectively, with a median ALBI score of -2.295. The ALBI grade was significantly associated with the three-month survival variable (p = 0.01; CI 95%). Using the ROC curve, we have determined a new cut-off point. The group of ALBI score ≤ -2.27 had an odds ratio of 2.549 (CI 95% 1.232-5.273) for three-month survival. The ALBI grade was associated with three-month survival after initial TACE in patients with HCC.

Item Type: Article
Uncontrolled Keywords: HCC, TACE, ALBI grade, survival
Subjects: R Medicine > RC Internal medicine > RC31-1245 Internal medicine
Divisions: 01. Fakultas Kedokteran > Ilmu Penyakit Dalam
Creators:
CreatorsNIM
Ummi MaimunahNIDN8896900016
Andri Pramana RestuUNSPECIFIED
Iswan Abbas NusiNIDN0028025003
Herrry PurbayuUNSPECIFIED
Titong SugihartonoNIDN8836800016
Ulfa KholiliNIDN0004047511
Budi WidodoNIDN8804800016
Muhammad MiftahussururNIDN0029097909
Husin ThamrinNIDN8825800016
Amie VidyaniNIDN0028018002
Poernomo Boedi SetiawanNIDN8886900016
Depositing User: Ika Rudianto
Date Deposited: 28 Apr 2023 07:26
Last Modified: 28 Apr 2023 07:52
URI: http://repository.unair.ac.id/id/eprint/125520
Sosial Share:

Actions (login required)

View Item View Item